AU2020347539B2 - Compositions for the treatment of solid tumors - Google Patents
Compositions for the treatment of solid tumorsInfo
- Publication number
- AU2020347539B2 AU2020347539B2 AU2020347539A AU2020347539A AU2020347539B2 AU 2020347539 B2 AU2020347539 B2 AU 2020347539B2 AU 2020347539 A AU2020347539 A AU 2020347539A AU 2020347539 A AU2020347539 A AU 2020347539A AU 2020347539 B2 AU2020347539 B2 AU 2020347539B2
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical composition
- compound
- weight
- acid
- composition comprises
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962900557P | 2019-09-15 | 2019-09-15 | |
| US62/900,557 | 2019-09-15 | ||
| PCT/IB2020/000745 WO2021048626A1 (en) | 2019-09-15 | 2020-09-14 | Compositions for the treatment of solid tumors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2020347539A1 AU2020347539A1 (en) | 2022-03-31 |
| AU2020347539B2 true AU2020347539B2 (en) | 2026-06-04 |
Family
ID=74866186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2020347539A Active AU2020347539B2 (en) | 2019-09-15 | 2020-09-14 | Compositions for the treatment of solid tumors |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220323411A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4031130A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP7822308B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN115066241A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2020347539B2 (cg-RX-API-DMAC10.html) |
| IL (1) | IL291351B1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2021048626A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016203468A1 (en) | 2015-06-15 | 2016-12-22 | Raziel Therapeutics Ltd. | Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof |
| WO2022234337A2 (en) * | 2021-05-06 | 2022-11-10 | Raziel Therapeutics Ltd. | Crystalline carbazole derivative |
| WO2024100533A1 (en) * | 2022-11-07 | 2024-05-16 | Raziel Therapeutics Ltd. | Crystalline carbazole derivative and methods of making thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010042445A1 (en) * | 2008-10-06 | 2010-04-15 | Cleveland Biolabs, Inc. | Carbazole compounds and therapeutic uses of the compounds |
| WO2013072915A1 (en) * | 2011-11-15 | 2013-05-23 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Tricyclic compounds, compositions comprising them and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0311406D0 (en) * | 2003-05-17 | 2003-06-25 | Queen Mary & Westfield College | Substituted phosphonate fluorescent sensors,and use thereof |
| WO2016203468A1 (en) * | 2015-06-15 | 2016-12-22 | Raziel Therapeutics Ltd. | Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof |
| AU2021213469B2 (en) * | 2020-01-28 | 2026-06-04 | Raziel Therapeutics Ltd. | Compositions for the treatment of angiolipoma |
-
2020
- 2020-09-14 EP EP20863979.9A patent/EP4031130A4/en active Pending
- 2020-09-14 CN CN202080078495.3A patent/CN115066241A/zh active Pending
- 2020-09-14 AU AU2020347539A patent/AU2020347539B2/en active Active
- 2020-09-14 JP JP2022515083A patent/JP7822308B2/ja active Active
- 2020-09-14 WO PCT/IB2020/000745 patent/WO2021048626A1/en not_active Ceased
- 2020-09-14 US US17/642,153 patent/US20220323411A1/en active Pending
- 2020-09-15 IL IL291351A patent/IL291351B1/en unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010042445A1 (en) * | 2008-10-06 | 2010-04-15 | Cleveland Biolabs, Inc. | Carbazole compounds and therapeutic uses of the compounds |
| WO2013072915A1 (en) * | 2011-11-15 | 2013-05-23 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Tricyclic compounds, compositions comprising them and uses thereof |
Non-Patent Citations (1)
| Title |
|---|
| CARMELA SATURNINO ET AL: "Inhibition of Human Topoisomerase II by N,N,N-Trimethylethanammonium Iodide Alkylcarbazole Derivatives", CHEMMEDCHEM COMMUNICATIONS, vol. 13, no. 24, (2018), pages 2635 - 2643, DOI: 10.1002/CMDC.201800546 * |
Also Published As
| Publication number | Publication date |
|---|---|
| IL291351B1 (en) | 2026-07-01 |
| JP2023503769A (ja) | 2023-02-01 |
| CN115066241A (zh) | 2022-09-16 |
| AU2020347539A1 (en) | 2022-03-31 |
| US20220323411A1 (en) | 2022-10-13 |
| EP4031130A4 (en) | 2023-10-11 |
| JP7822308B2 (ja) | 2026-03-02 |
| EP4031130A1 (en) | 2022-07-27 |
| IL291351A (en) | 2022-05-01 |
| WO2021048626A1 (en) | 2021-03-18 |